| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ABBV | Common Stock, $0.01 par value | Tax liability | $955,628 | -5,339 | -28% | $178.99 | 13,872 | 28 Feb 2024 | Direct | |
| transaction | ABBV | Common Stock, $0.01 par value | Sale | $908,688 | -5,144 | -42% | $176.65 | 6,983 | 29 Feb 2024 | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $176.65 to $176.68, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F2 | The reporting person transferred 1,745 shares of common stock to his former spouse pursuant to a domestic relations order since his last ownership report and has ceased to be the beneficial owner of such shares. |